BioSpace News Archive

Brown Gibbons Lang & Company (“BGL”) is pleased to announce the merger of Synergy Surgicalists (“Synergy”), one of the nation’s top providers of surgicalist staffing to acute care settings, with EA Health Solutions (“EA Health”), the nation’s leading provider of specialty physician on-call compensation solutions and physician staffing services.

NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave”) (CSE: SPOR) (Frankfurt: 0XM2) (OTC: TRMND), is pleased to announce that it will support the Delos Psyche Research Group (“Delos Psyche”) in its study designed to determine the impact of ingesting small amounts of hallucinogenic or psychedelic substances such as lysergic acid diethylamide (“LSD”) for medicinal or therapeutic purposes.

Burgeoning investment in the infrastructure pertaining to healthcare is expected to bode well for the growth of the global patient positioning equipment market, states Persistence Market Research (PMR) in a research report. The report is titled, “Global Market Study on Patient Positioning Equipment: Surgical Tables Product Type Segment Expected to be the Most Attractive Segment During 2017 – 2025.”

Company is leveraging its integrin platform technology to improve effectiveness of immunotherapies, including Covid-19 vaccines

Today Ameda officially announced its launch of Ameda Mya Joy™ — the latest addition to its family of hospital strength personal breast pumps. Ameda Mya Joy combines safe & powerful pumping in an incredibly small and portable design for moms on-the-go.

Aging induces various skin related problems o defects such as wrinkles, lines etc. Various medical treatments for curing these disorders are being developed. Skin rejuvenation essentially is improving the skin appearance with the help of advanced medical treatments.

On 16 June, Lonza will host a free 60-minute webinar on the latest regulatory developments surrounding the use of the recombinant Factor C (rFC) assay for endotoxin detection in parenteral pharmaceuticals and implantable medical devices.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that the company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Thursday, June 11, 2020 at 3:50 pm EDT.

Menlo Therapeutics Inc. (“Menlo”) (Nasdaq: MNLO), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering

NuVasive, Inc. (NASDAQ: NUVA) announced today that it closed the issuance of an additional $50.0 million in aggregate principal amount of the 1.00% Convertible Senior Notes due 2023 (the “Convertible Notes”), pursuant to the exercise in full of the initial purchasers’ option to purchase such additional notes